17α-estradiol alleviates age-related metabolic and inflammatory dysfunction in male mice without inducing feminization

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 72, Issue 1, 2017, Pages 3-15

  Stout, Michael B ^a   Steyn, Frederik J ^b   Jurczak, Michael J ^c   Camporez, Joao Paulo G ^d   Zhu, Yi ^a   Hawse, John R ^a   Jurk, Diana ^e   Palmer, Allyson K ^a   Xu, Ming ^a   Pirtskhalava, Tamar ^a   Evans, Glenda L ^a   De Souza Santos, Roberta ^f   Frank, Aaron P ^f   White, Thomas A ^a   Monroe, David G ^a   Singh, Ravinder J ^a   Casaclang Verzosa, Grace ^a   Miller, Jordan D ^a   Clegg, Deborah J ^f   LeBrasseur, Nathan K ^a   Von Zglinicki, Thomas ^e   Shulman, Gerald I ^d   Tchkonia, Tamara ^a   Kirkland, James L ^a   more..

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

^f CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

17 Estradiol; Adipose tissue; Hypothalamus; Inflammation; Metabolism

Indexed keywords

ESTRADIOL; ESTROGEN;

AGING; ANIMAL; BODY MASS; C57BL MOUSE; DRUG EFFECTS; FEMINIZATION; INTRAABDOMINAL FAT; LIPID METABOLISM; MALE; MOUSE; OBESITY; PHYSIOLOGY;

ADIPOSITY; AGING; ANIMALS; BODY MASS INDEX; ESTRADIOL; ESTROGENS; FEMINIZATION; INTRA-ABDOMINAL FAT; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL;

EID: 85014718363     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glv309     Document Type: Article

References (89)

1. Christensen K, Doblhammer G, Rau R, Vaupel JW. Ageing populations: the challenges ahead. Lancet. 2009;374:1196-1208. doi:10.1016/S0140-6736(09)61460-4
2. Fabbri E, Zoli M, Gonzalez-Freire M, Salive ME, Studenski SA, Ferrucci L. Aging and multimorbidity: new tasks, priorities, and frontiers for integrated gerontological and clinical research. J Am Med Dir Assoc. 2015;16:640-647. doi:10.1016/j.jamda.2015.03.013
3. Fabbri E, An Y, Zoli M, et al. Aging and the burden of multimorbidity: associations with inflammatory and anabolic hormonal biomarkers. J Gerontol A Biol Sci Med Sci. 2015;70:63-70. doi:10.1093/gerona/glu127
4. Johnson SC, Rabinovitch PS, Kaeberlein M. mTOR is a key modulator of ageing and age-related disease. Nature. 2013;493:338-345. doi:10.1038/nature11861
5. Salminen A, Kaarniranta K. AMP-activated protein kinase (AMPK) controls the aging process via an integrated signaling network. Ageing Res Rev. 2012;11:230-241. doi:10.1016/j.arr.2011.12.005
6. Fontana L, Partridge L. Promoting health and longevity through diet: from model organisms to humans. Cell. 2015;161:106-118. doi:10.1016/j. cell.2015.02.020
7. Masoro EJ. Caloric restriction-induced life extension of rats and mice: a critique of proposed mechanisms. Biochim Biophys Acta. 2009;1790:1040-1048. doi:10.1016/j.bbagen.2009.02.011
8. Petersen KF, Dufour S, Befroy D, Lehrke M, Hendler RE, Shulman GI. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes. 2005;54:603-608.
9. Petersen KF, Dufour S, Morino K, Yoo PS, Cline GW, Shulman GI. Reversal of muscle insulin resistance by weight reduction in young, lean, insulinresistant offspring of parents with type 2 diabetes. Proc Natl Acad Sci USA. 2012;109:8236-8240. doi:10.1073/pnas.1205675109
10. Stout M, Tchkonia T, Kirkland J. The aging adipose organ: lipid redistribution, inflammation, and cellular senescence. In: FantuzziG, BraunschweigC, eds. Adipose Tissue and Adipokines in Health and Disease (Nutrition and Health). New York, NY: Humana Press; 2014:69-80.
11. Kuk JL, Saunders TJ, Davidson LE, Ross R. Age-related changes in total and regional fat distribution. Ageing Res Rev. 2009;8:339-348. doi:10.1016/j.arr.2009.06.001
12. Flannery C, Dufour S, Rabøl R, Shulman GI, Petersen KF. Skeletal muscle insulin resistance promotes increased hepatic de novo lipogenesis, hyperlipidemia, and hepatic steatosis in the elderly. Diabetes. 2012;61:2711-2717. doi:10.2337/db12-0206
13. Petersen KF, Befroy D, Dufour S, et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science. 2003;300:1140-1142. doi:10.1126/science.1082889
14. Shulman GI. Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease. New Engl J Med. 2014;371:2237-2238. doi:10.1056/NEJMc1412427
15. Muzumdar R, Allison DB, Huffman DM, et al. Visceral adipose tissue modulates mammalian longevity. Aging Cell. 2008;7:438-440. doi:10.1111/j.1474-9726.2008.00391.x
16. Kuk JL, Katzmarzyk PT, Nichaman MZ, Church TS, Blair SN, Ross R. Visceral fat is an independent predictor of all-cause mortality in men. Obesity. 2006;14:336-341. doi:10.1038/oby.2006.43
17. Villareal DT, Banks M, Sinacore DR, Siener C, Klein S. Effect of weight loss and exercise on frailty in obese older adults. Arch Intern Med. 2006;166:860-866. doi:10.1001/archinte.166.8.860
18. Gustafson B, Gogg S, Hedjazifar S, Jenndahl L, Hammarstedt A, Smith U. Inflammation and impaired adipogenesis in hypertrophic obesity in man. Am J Physiol Endocrinol Metab. 2009;297:E999-E1003. doi:10.1152/ajpendo.00377.2009
19. Villareal DT, Chode S, Parimi N, et al. Weight loss, exercise, or both and physical function in obese older adults. New Engl J Med. 2011;364:1218-1229. doi:10.1056/NEJMoa1008234
20. Rolland Y, Kim MJ, Gammack JK, Wilson MM, Thomas DR, Morley JE. Office management of weight loss in older persons. Am J Med. 2006;119:1019-1026. doi:10.1016/j.amjmed.2006.02.039
21. Morley JE, Chahla E, Alkaade S. Antiaging, longevity and calorie restriction. Curr Opin Clin Nutrition Metab Care. 2010;13:40-45. doi:10.1097/MCO.0b013e3283331384
22. Dirks AJ, Leeuwenburgh C. Caloric restriction in humans: potential pitfalls and health concerns. Mech Ageing Dev. 2006;127:1-7. doi:10.1016/j. mad.2005.09.001
23. Harrison DE, Strong R, Allison DB, et al. Acarbose, 17-alpha-estradiol, and nordihydroguaiaretic acid extend mouse lifespan preferentially in males. Aging Cell. 2014;13:273-282. doi:10.1111/acel.12170
24. Anstead GM, Carlson KE, Katzenellenbogen JA. The estradiol pharmacophore: ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site. Steroids. 1997;62:268-303.
25. Littlefield BA, Gurpide E, Markiewicz L, McKinley B, Hochberg RB. A simple and sensitive microtiter plate estrogen bioassay based on stimulation of alkaline phosphatase in Ishikawa cells: estrogenic action of delta 5 adrenal steroids. Endocrinology. 1990;127:2757-2762. doi:10.1210/endo-127-6-2757
26. Dykens JA, Moos WH, Howell N. Development of 17alpha-estradiol as a neuroprotective therapeutic agent: rationale and results from a phase I clinical study. Ann NY Acad Sci. 2005;1052:116-135. doi:10.1196/annals.1347.008
27. Toran-Allerand CD. Estrogen and the brain: beyond ER-alpha, ERbeta, and 17beta-estradiol. Ann NY Acad Sci. 2005;1052:136-144. doi:10.1196/annals.1347.009
28. Ikeda T, Makino Y, Yamada MK. 17?-estradiol is generated locally in the male rat brain and can regulate GAD65 expression and anxiety. Neuropharmacology. 2015;90:9-14. doi:10.1016/j.neuropharm.2014.10.019
29. Toran-Allerand CD, Tinnikov AA, Singh RJ, Nethrapalli IS. 17alphaestradiol: a brain-active estrogen? Endocrinology. 2005;146:3843-3850. doi:10.1210/en.2004-1616
30. Perez E, Liu R, Yang SH, Cai ZY, Covey DF, Simpkins JW. Neuroprotective effects of an estratriene analog are estrogen receptor independent in vitro and in vivo. Brain Res. 2005;1038:216-222. doi:10.1016/j.brainres. 2005.01.026
31. Ozacmak VH, Sayan H. The effects of 17beta estradiol, 17alpha estradiol and progesterone on oxidative stress biomarkers in ovariectomized female rat brain subjected to global cerebral ischemia. Physiol Res. 2009;58:909-912.
32. Green PS, Simpkins JW. Estrogens and estrogen-like non-feminizing compounds. Their role in the prevention and treatment of Alzheimer's disease. Ann NY Acad Sci. 2000;924:93-98.
33. Akasaki Y, Ouchi N, Izumiya Y, Bernardo BL, Lebrasseur NK, Walsh K. Glycolytic fast-twitch muscle fiber restoration counters adverse age-related changes in body composition and metabolism. Aging Cell. 2014;13:80-91. doi:10.1111/acel.12153
34. Lublinsky S, Luu YK, Rubin CT, Judex S. Automated separation of visceral and subcutaneous adiposity in in vivo microcomputed tomographies of mice. J Digital Imaging. 2009;22:222-231. doi:10.1007/s10278-008-9152-x
35. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402-408. doi:10.1006/meth.2001.1262
36. Morselli E, Fuente-Martin E, Finan B, et al. Hypothalamic PGC-1alpha protects against high-fat diet exposure by regulating ERalpha. Cell Reports. 2014;9:633-645. doi:10.1016/j.celrep.2014.09.025
37. Baker DJ, Wijshake T, Tchkonia T, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011;479:232-236. doi:10.1038/nature10600
38. Angermuller S, Fahimi HD. Imidazole-buffered osmium-tetroxide-an excellent stain for visualization of lipids in transmission electron-microscopy. Histochem J. 1982;14:823-835. doi:10.1007/Bf01033631
39. Stout MB, Liu LF, Belury MA. Hepatic steatosis by dietary-conjugated linoleic acid is accompanied by accumulation of diacylglycerol and increased membrane-associated protein kinase C epsilon in mice. Mol Nutrition Food Res. 2011;55:1010-1017. doi:10.1002/mnfr.201000413
40. Kliewer KL, Ke JY, Lee HY, et al. Short-term food restriction followed by controlled refeeding promotes gorging behavior, enhances fat deposition, and diminishes insulin sensitivity in mice. J Nutritional Biochem. 2015;26:721-728. doi:10.1016/j.jnutbio.2015.01.010
41. Johnson MS, Jumbo-Lucioni P, Watts AJ, Allison DB, Nagy TR. Effect of dairy supplementation on body composition and insulin resistance in mice. Nutrition. 2007;23:836-843. doi:10.1016/j.nut.2007.08.004
42. Marshall JM, Flechtner AD, La Perle KM, Gunn JS. Visualization of extracellular matrix components within sectioned Salmonella biofilms on the surface of human gallstones. PLoS One. 2014;9:e89243. doi:10.1371/journal.pone.0089243
43. Jurk D, Wilson C, Passos JF, et al. Chronic inflammation induces telomere dysfunction and accelerates ageing in mice. Nature Commun. 2014;2:4172. doi:10.1038/ncomms5172
44. Monroe DG, Johnsen SA, Subramaniam M, et al. Mutual antagonism of estrogen receptors alpha and beta and their preferred interactions with steroid receptor coactivators in human osteoblastic cell lines. J Endocrinol. 2003;176:349-357.
45. Modder UI, Oursler MJ, Khosla S, Monroe DG. Wnt10b activates the Wnt, notch, and NFkappaB pathways in U2OS osteosarcoma cells. J Cell Biochem. 2011;112:1392-1402. doi:10.1002/jcb.23048
46. Roos CM, Hagler M, Zhang B, Oehler EA, Arghami A, Miller JD. Transcriptional and phenotypic changes in aorta and aortic valve with aging and MnSOD deficiency in mice. Am J Physiol Heart Circul Physiol. 2013;305:H1428-H1439. doi:10.1152/ajpheart.00735.2012
47. List EO, Berryman DE, Funk K, et al. Liver-specific GH receptor gene-disrupted (LiGHRKO) mice have decreased endocrine IGF-I, increased local IGF-I, and altered body size, body composition, and adipokine profiles. Endocrinology. 2014;155:1793-1805. doi:10.1210/en.2013-2086
48. Tchkonia T, Morbeck DE, Von Zglinicki T, et al. Fat tissue, aging, and cellular senescence. Aging Cell. 2010;9:667-684. doi:10.1111/j.1474-9726.2010.00608.x
49. Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nature Rev Immunol. 2011;11:85-97. doi:10.1038/nri2921
50. Xu Y, Nedungadi TP, Zhu L, et al. Distinct hypothalamic neurons mediate estrogenic effects on energy homeostasis and reproduction. Cell Metab. 2011;14:453-465. doi:10.1016/j.cmet.2011.08.009
51. Michaud M, Balardy L, Moulis G, et al. Proinflammatory cytokines, aging, and age-related diseases. J Am Med Dir Assoc. 2013;14:877-882. doi:10.1016/j.jamda.2013.05.009
52. Starr ME, Evers BM, Saito H. Age-associated increase in cytokine production during systemic inflammation: adipose tissue as a major source of IL-6. J Gerontol A Biol Sci Med Sci. 2009;64:723-730. doi:10.1093/gerona/glp046
53. Cartier A, Cote M, Lemieux I, et al. Age-related differences in inflammatory markers in men: contribution of visceral adiposity. Metab Clin Exp. 2009;58:1452-1458. doi:10.1016/j.metabol.2009.04.025
54. Zhu Y, Tchkonia T, Pirtskhalava T, et al. The Achilles' heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell. 2015;14:644-658. doi:10.1111/acel.12344
55. Stout MB, Tchkonia T, Pirtskhalava T, et al. Growth hormone action predicts age-related white adipose tissue dysfunction and senescent cell burden in mice. Aging. 2014;6:575-586.
56. Lin HH, Stacey M, Stein-Streilein J, Gordon S. F4/80: the macrophagespecific adhesion-GPCR and its role in immunoregulation. Adv Exp Med Biol. 2010;706:149-156.
57. Coppe JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol. 2010;5:99-118. doi:10.1146/annurev-pathol-121808-102144
58. Meier JJ, Bonadonna RC. Role of reduced beta-cell mass versus impaired beta-cell function in the pathogenesis of type 2 diabetes. Diabetes Care. 2013;36(suppl 2):S113-S119. doi:10.2337/dcS13-2008
59. Palmer AK, Tchkonia T, LeBrasseur NK, Chini EN, Xu M, Kirkland JL. Cellular senescence in type 2 diabetes: a therapeutic opportunity. Diabetes. 2015;64:2289-2298. doi:10.2337/db14-1820
60. Aravinthan A, Scarpini C, Tachtatzis P, et al. Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease. J Hepatol. 2013;58:549-556. doi:10.1016/j.jhep.2012.10.031
61. Gower BA, Nyman L. Associations among oral estrogen use, free testosterone concentration, and lean body mass among postmenopausal women. J Clin Endocrinol Metab. 2000;85:4476-4480. doi:10.1210/jcem.85.12.7009
62. Castles CG, Oesterreich S, Hansen R, Fuqua SAW. Auto-regulation of the estrogen receptor promoter. J Steroid Biochem Mol Biol. 1997;62:155-163. doi:10.1016/S0960-0760(97)00023-X
63. Mosca L, Collins P, Herrington DM, et al. Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 2001;104:499-503.
64. Mauvais-Jarvis F, Clegg DJ, Hevener AL. The role of estrogens in control of energy balance and glucose homeostasis. Endocrine Rev. 2013;34:309-338. doi:10.1210/er.2012-1055
65. Lopez M, Tena-Sempere M. Estrogens and the control of energy homeostasis: a brain perspective. Trends Endocrinol Metab. 2015;26:411-421. doi:10.1016/j.tem.2015.06.003
66. Reuben DB, Cheh AI, Harris TB, et al. Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons. J Am Geriatr Soc. 2002;50:638-644.
67. Slawik M, Vidal-Puig AJ. Lipotoxicity, overnutrition and energy metabolism in aging. Ageing Res Rev. 2006;5:144-164. doi:10.1016/j. arr.2006.03.004
68. Goodpaster BH, Krishnaswami S, Harris TB, et al. Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Arch Int Med. 2005;165:777-783. doi:10.1001/archinte.165.7.777
69. Goodpaster BH, Krishnaswami S, Resnick H, et al. Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes Care. 2003;26:372-379.
70. Camporez JP, Jornayvaz FR, Lee HY, et al. Cellular mechanism by which estradiol protects female ovariectomized mice from high-fat diet-induced hepatic and muscle insulin resistance. Endocrinology. 2013;154:1021-1028. doi:10.1210/en.2012-1989
71. Lenard NR, Berthoud HR. Central and peripheral regulation of food intake and physical activity: pathways and genes. Obesity. 2008;16(suppl 3):S11-S22. doi:10.1038/oby.2008.511
72. Cowley MA, Smart JL, Rubinstein M, et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature. 2001;411:480-484. doi:10.1038/35078085
73. Millington GW. The role of proopiomelanocortin (POMC) neurones in feeding behaviour. Nutrition Metab. 2007;4:18. doi:10.1186/1743-7075-4-18
74. Ma XH, Muzumdar R, Yang XM, Gabriely I, Berger R, Barzilai N. Aging is associated with resistance to effects of leptin on fat distribution and insulin action. J Gerontol A Biol Sci Med Sci. 2002;57:B225-B231.
75. Sainz N, Barrenetxe J, Moreno-Aliaga MJ, Martinez JA. Leptin resistance and diet-induced obesity: central and peripheral actions of leptin. Metab Clin Exp. 2015;64:35-46. doi:10.1016/j.metabol.2014.10.015
76. Hirosawa M, Minata M, Harada KH, Hitomi T, Krust A, Koizumi A. Ablation of estrogen receptor alpha (ERalpha) prevents upregulation of POMC by leptin and insulin. Biochem Biophys Res Commun. 2008;371:320-323. doi:10.1016/j.bbrc.2008.04.073
77. Davis KE, Neinast MD, Sun K, et al. The sexually dimorphic role of adipose and adipocyte estrogen receptors in modulating adipose tissue expansion, inflammation, and fibrosis. Mol Metab. 2013;2:227-242. doi:10.1016/j. molmet.2013.05.006
78. Andersson T, Soderstrom I, Simonyte K, Olsson T. Estrogen reduces 11beta-hydroxysteroid dehydrogenase type 1 in liver and visceral, but not subcutaneous, adipose tissue in rats. Obesity. 2010;18:470-475. doi:10.1038/oby.2009.294
79. Salminen A, Hyttinen JM, Kaarniranta K. AMP-activated protein kinase inhibits NF-kappaB signaling and inflammation: impact on healthspan and lifespan. J Mol Med. 2011;89:667-676.
80. Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol A Biol Sci Med Sci. 2014;69(suppl 1):S4-S9. doi:10.1093/gerona/glu057
81. Moiseeva O, Deschenes-Simard X, St-Germain E, et al. Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-kappaB activation. Aging Cell. 2013;12:489-498.
82. Laberge RM, Sun Y, Orjalo AV, et al. MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation. Nature Cell Biol. 2015;17:1049-1061. doi:10.1038/ncb3195
83. Lumeng CN, Liu J, Geletka L, et al. Aging is associated with an increase in T cells and inflammatory macrophages in visceral adipose tissue. J Immunol. 2011;187:6208-6216. doi:10.4049/jimmunol.1102188
84. Morley JE, Sinclair A. The metabolic syndrome in older persons: a loosely defined constellation of symptoms or a distinct entity? Age Ageing. 2009;38:494-497. doi:10.1093/ageing/afp105
85. Perry RJ, Camporez JP, Kursawe R, et al. Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell. 2015;160:745-758. doi:10.1016/j.cell.2015.01.012
86. Sheedfar F, Di Biase S, Koonen D, Vinciguerra M. Liver diseases and aging: friends or foes? Aging Cell. 2013;12:950-954. doi:10.1111/acel.12128
87. Stratakis CA, Vottero A, Brodie A, et al. The aromatase excess syndrome is associated with feminization of both sexes and autosomal dominant transmission of aberrant P450 aromatase gene transcription. J Clin Endocrinol Metab. 1998;83:1348-1357. doi:10.1210/jcem.83.4.4697
88. Howard BV, Rossouw JE. Estrogens and cardiovascular disease risk revisited: the Women's Health Initiative. Curr Opin Lipidol. 2013;24:493-499. doi:10.1097/MOL.0000000000000022
89. Abbott RD, Launer LJ, Rodriguez BL, et al. Serum estradiol and risk of stroke in elderly men. Neurology. 2007;68:563-568. doi:10.1212/01. wnl.0000254473.88647.ca